Experiments were conducted in hamsters to determine whether the phase response curve (PRC) to injections of the short-acting benzodiazepine triazolam is a fixed or a labile property of the circadian clock. The results indicated that (1) both the shape and the amplitude of the PRC to triazolam generated on the first day of transfer from a light-dark cycle (LD 14:10) to constant darkness (DD) (i.e., PRC LD ) were different from those of the PRC generated after many days in DD (PRC DD ); and (2) the phase-shifting effects of triazolam on the activity rhythms of hamsters transferred from LD 14:10 or 12:12 to DD changed dramatically within the fist 8-9 days spent in DD. In an attempt to accelerate the resynchronization of the circadian clock of hamsters subjected to an 8-hr advance in the LD cycle, triazolam was given to the animals at a time selected on the basis of the characteristics of PRC LD . The activity rhythms of five of eight triazolam-treated animals were resynchronized to the new LD cycle within 2-4 days after the shift, whereas those of most of the control animals were resynchronized 21-29 days after the shift. These findings suggest that attempts to use pharmacological or nonpharmacological tools to phase-shift circadian clocks under entrained conditions should take into account information derived from PRCs generated at the time of transition from entrained to freerunning conditions.
The light-dark (LD) cycle is the primary environmental signal that synchronizes circadian clocks to the 24-hr changes in the physical environment (Aschoff, 1981; Pittendrigh, 1981) . Light is thought to entrain circadian rhythms by inducing discrete daily phase advances or phase delays in the clock underlying these rhythms (Pittendrigh, 1981; DeCoursey, 1986) . Phase shifts in circadian rhythms can be induced by single pulses of light in animals (or plants) free-running in constant darkness (DD), and both the magnitude and the direction of phase shifts are dependent upon the circadian time (CT) at which light pulses are delivered. Plotting the phase shifts as a function of time of administration yields a phase response curve (PRC) to a given environmental stimulus (Aschoff, 1981; Pittendrigh, 1981) . PRCs represent one of the most direct means of studying fundamental properties of circadian clocks underlying circadian rhythms. Many different PRCs have recently been generated in response to various pharmacological and nonpharmacological stimuli (e.g., benzodiazepines, protein synthesis inhibitors, exposure to a novel running wheel) (Mrosovsky, 1988;  Turek and Losee-Olson, 1986; Turek, 1987; Wickland and Turek, 1991) , as well as to light.
Although PRCs have been generated to various stimuli in many species, little is known about the lability of PRCs. The hypothesis that PRCs might be labile is supported by the observation that another fundamental property of the circadian clock, its period length, is not fixed and changes over time. For example, when golden hamsters are transferred from an LD cycle to DD, the initial free-running period of the activity rhythm is often less than 24 hr, and over the next few weeks the period of this rhythm gradually lengthens until reaching a steady-state period averaging about 24.1 to 24.2 hr after many weeks in DD (Pittendrigh and Daan, 1974) . Similar long-term changes in the free-running period of the circadian clock have been observed in other vertebrate species, including sparrows and humans (Eskin, 1971 ; Aschoff and Wever, 1976) .
The possibility that the PRC to a particular stimulus might also change as a function of time in DD has received little attention in vertebrates. In attempting to phase-shift the circadian clock with the short-acting benzodiazepine triazolam, immediately after a phase shift in the LD cycle (0. Van Reeth, unpublished results), we obtained phase shifts in the activity rhythm that were not compatible with the known PRC to triazolam (Turek and Losee-Olson, 1986 ). This finding led us to question whether the PRC to triazolam might vary, depending on the amount of time an animal was exposed to constant environmental conditions. The present results demonstrate that the shape of the PRC to injections of triazolam on the first day of DD is different from the shape of the PRC after many days in DD, and suggest that attempts to use agents to phase-shift the circadian clock under entrained conditions should take into account information derived from PRCs generated at the time of transition from entrained to free-running conditions.
MATERIALS AND METHODS

ANIMALS AND HOUSING
Male golden hamsters (Mesocricetus auratus), purchased from Charles River Lakeview (Newfield, NJ) or bred in our colony from hamsters purchased from this supplier, were housed four or five to a cage in an LD cycle (LD 14: 10) with light intensity z= 600 lux at cage floor level (measured with a United Detector Technology light meter) until they were 9-10 weeks of age. Animals were then transferred to individual cages equipped with running wheels connected to an event recorder to allow for continuous recording of locomotor activity (Ellis et al., 1982) . Animals in running-wheel cages were subsequently kept in dim LD 14:10 (n = 37) or LD 12:12 (n = 12) (light intensity == 10-30 lux at cage floor level) in light-tight ventilated boxes, with five cages per box. Food and water were freely available throughout the experiments. TRANSFER FROM LD 14:10 TO DD After 5 weeks under dim LD 14: 10, a first group of 20 hamsters was transferred to DD at the usual time of lights-off. These animals were subjected to an i.p. injection of either 0.1 1 ml of vehicle dimethylsulfoxide (DMSO; Sigma, St. Louis, MO), or 2.5 mg of triazolam (Halcion@; Upjohn, Kalamazoo, MI) dissolved in vehicle, at various CTs during the first day in DD. The dose of 2.5 mg of triazolam per animal was selected in all experiments on the basis of previous results demonstrating that at this particular dose, triazolam induces maximum phase shifts in the activity rhythm of hamsters maintained in DD or constant light (LL) (Turek and Losee-Olson, 1986 , 1987 . Vehicle was injected at CT 6 or CT 18, and triazolam at CT 3, 6, 9, 12, 15, 18, 21, or 24. The first CT selected for administration of triazolam was a phase reference point located 3 hr afer the onset of activity on the first day in DD (i.e., CT 15), and the last CT for administration of triazolam was a time around the expected onset of activity on the second day in DD (i.e., CT 12). After the injection, hamsters were left undisturbed for 10 days in DD before being returned to LD 14:10 for 18-22 days, in order to allow stable entrainment of the activity rhythm to the LD cycle. During the course of this experiment, four hamsters died and were replaced by animals of the same cohort. Animals were subjected to this procedure from one to four consecutive times during the course of the experiment, with vehicle or triazolam never being given to any individual animal more than once at the same CT.
Another group of 13 hamsters was transferred to DD after 12 days under dim LD 14:10. Animals were repeatedly subjected to a single injection of 0.1 ml of vehicle (n = 6) or 2.5 mg of triazolam dissolved in vehicle (n = 7) at CT 24 on days, 1, 8, 16, and 23 of DD. Both the vehicle-and triazolam-treated animals received a final injection of triazolam at CT 24 on day 34 of DD.
TRANSFER FROM LD 12 :12 TO DD After 21 days of habituation to the dim LD 12:12, 12 hamsters were transferred to DD at the usual time of lights-off. Animals were repeatedly injected with 0.1 ml of vehicle (n = 6) or 2.5 mg of triazolam (n = 6) at CT 24 on days, 1, 9, and 25 of DD. Both the vehicleand triazolam-treated animals received a final injection of triazolam at CT 24 on day 39 of DD.
EIGHT-HOUR ADVANCE SHIFT IN THE LD CYCLE
After 11 days of habituation to the cage with a running wheel under dim LD 14:10, 19 hamsters were subjected to an abrupt 8-hr advance shift in the LD cycle (i.e., an advance in the time of lights-on by 8 hr). Thus, on day I of the shift, lights were turned on 2 hr after they were turned off, and the new LD cycle was maintained thereafter. The animals received an i.p. injection of either 0.1 ml of vehicle (n = 10) or 2.5 mg of triazolam (n = 9) precisely 12 hr after the actual onset of locomotor activity the day of the shift, and the time needed for the activity rhythm to resynchronize to the new LD cycle (i.e., the transient period) was assessed in each animal of both groups.
DATA ANALYSIS
The phase-shifting effects of vehicle or triazolam on the circadian rhythm of locomotor activity were assessed as follows. Using the daily onset of wheel-running activity for the last 5-10 days preceding treatment as reference points, we calculated a time of expected activity onset for the day after treatment. In addition, the daily onsets of activity for the 5-10 days after treatment (i.e., once transient cycles were completed and a steady-state phase was achieved) were used as reference points, and a time for the predicted activity onset for the cycle after the injection was determined. The expected time of activity onset was subtracted from the predicted time of activity onset the day after treatment, yielding the magnitude of the shift in the activity rhythm induced by treatment. Thus, a negative value indicated a delay in the onset of activity, whereas a positive value indicated an advance. Mean values of phase shifts observed in different groups of animals are presented with the standard error of the mean (SEM). A paired Student's t test for dependent samples was used to compare phase shifts of the activity rhythm within groups of animals repeatedly injected with triazolam at the same CT during the course of an experiment. An unpaired Student's t test was used to compare mean phase shifts between different groups of animals injected with triazolam at the same CT during the course of an experiment.
When hamsters were subjected to the 8-hr advance shift in the LD cycle, the time taken for re-entrainment to the new LD cycle (defined as the number of days needed to begin locomotor activity within 30 min of lights-off of the new LD cycle) was compared between vehicleand triazolam-treated animals by means of an unpaired Student's t test. The activity rhythms of two animals subjected to the advance in the LD cycle were too erratic to allow for an accurate determination of activity onset, and their data were not included in the statistical analysis.
RESULTS
Activity rhythms of animals from all groups were stably entrained to the LD cycle before any experimental procedure was performed. Among the various groups of animals maintained in DD that were injected with the vehicle DMSO, only a single animal showed a clear phase shift (i.e., >15 min) in the activity rhythm in response to the vehicle injection.
TRANSFER FROM LD 14:10 TO DD In the group of 20 hamsters repeatedly transferred from LD 14: 10 to DD during the course of the experiment, triazolam treatment on the first day of DD resulted in large phase advances in activity rhythms after injections given at either CT 24, 3, 6, or 9 ( Fig. 1 ). Maximal phase advances were observed at CT 24 (191 ± 37 min; n = 7), with five of seven animals showing phase advances --230 min. Administration of triazolam at CT 12 or CT 15 had no phase-shifting effect or resulted in small phase delays in activity rhythms. Injections of triazolam at CT 18 or CT 21 resulted in clear phase delays in activity rhythms, with maximal phase delays observed at CT 21 (-34 ± 15 min; n = 8). Mean phase shifts in control animals injected with vehicle on day 1 of DD at CT 6 or CT 18 were 9 ± 2 and 4 ± 4 min, respectively. Representative sections of activity records of hamsters injected with triazolam at four different CTs during the first day the animals were transferred from LD 14: 10 to DD are shown in Figure 2 .
Similarly, in the group of 13 hamsters transferred from LD 14:10 to DD and repeatedly injected with triazolam in DD at CT 24, large phase advances were observed in the activity rhythms of six of seven animals after an injection of triazolam on the first day of DD, with the mean phase advance of the group averaging 155 ± 35 min. However, after 8 days in DD, similar treatment with triazolam at CT 24 resulted in phase delays in the activity rhythms of five of these seven animals (Fig. 3) ; the mean phase delay of the group averaged -31 1 ± 12 min, a value significantly different from the mean phase shift observed in response FIGURE 1. The solid line represents the PRC (a plot of the mean [ ± SEM] phase shifts in the activity rhythm of hamsters as a function of the CT of drug administration) generated in response to injections of 2.5 mg of triazolam on the first day of transfer from LD 14:10 to DD. A value above the straight line at 0 indicates an advance in the onset of activity; a value below the line indicates a delay. The values within parentheses indicate the numbers of trials performed at each CT tested. The dashed line shows the PRC generated by a similar treatment with triazolam in hamsters maintained in DD for at least 2 weeks before the first treatment with triazolam. (Adapted with permission from Turek and Losee-Olson, 1986.) to triazolam on day 1 of DD (p < 0.005, paired Student's t test) (Fig. 3) . Similarly, injections of triazolam at CT 24 on days 16, 23, and 34 of DD resulted in mean phase delays averaging, respectively, -24 ± 22 min, -8 ± 6 min, and -21 ± 13 min. The six animals that received only one injection of triazolam at CT 24 on day 34 of DD exhibited phase delays in their activity rhythms (mean phase delay = -35 ± 13 min) that were similar to phase shifts observed in the other group of animals in response to triazolam on day 34 of DD, but significantly different from the response to triazolam on day 1 of DD (p < 0.002, unpaired Student's t test). The mean phase shifts for these six animals in response to vehicle injections at CT 24 on days, 1, 8, 16, and 23 were -2 ± 2, 1 ± 2, -4 ± 5, and 3 ± 3 min, respectively. A representative section of the locomotor activity record of one animal transferred from LD 14:10 that received an injection of triazolam at CT 24 on days 1 and 8 of DD is shown in the top right panel of Figure 3 . TRANSFER FROM LD 12 :12 TO DD Similar to the results observed in animals transferred from LD 14:10 to DD, four of six animals that were transferred from LD 12:12 and injected with triazolam at CT 24 during the first day in DD exhibited large phase advances in their activity rhythms. The two remaining animals of this group exhibited either no phase shift or a 30-min phase delay. The mean phase advance of the group in response to triazolam was 76 ~-39 min (Fig. 3 , FIGURE 2. Representative sections from the locomotor activity records of four hamsters for a 6-day period before and a 9-day period after they were injected with 2.5 mg of triazolam at various circadian times on the first day after transfer from LD to DD. Each line represents a single 24-hr period, and successive days are plotted from top to bottom in each record. Prior to treatment with triazolam, the animals were entrained to dim LD 14:10, represented above the top panel. The CT of the triazolam injection is noted to the left of each record, and the exact time of the injection is designated by an asterisk. After the triazolam injection, hamsters were left undisturbed in DD. bottom left panel). After 9 days in DD, five of the six animals showed phase delays in their activity rhythms in response to an injection of triazolam at CT 24; the mean phase delay of the group was -27 ± 3 min, a value significantly different from the mean phase shift observed in response to triazolam on day 1 of DD (p < 0.05, paired Student's t test). Similarly, injections of triazolam at CT 24 on day 25 or 39 of DD resulted in mean phase delays averaging, respectively, -34 ± 22 and -56 ± 6 min. The six control hamsters that were only subjected to one injection of triazolam at CT 24 on day 39 of DD exhibited phase delays in their activity rhythms (mean phase delay = -41 ± 12 min) that were similar to phase shifts observed in the other group of animals in response to triazolam on day 39 of DD, but significantly different from the latter group's response to triazolam on day 1 of DD (p < 0.02, unpaired Student's t test). A representative section of the locomotor activity record of one animal transferred from LD 12:12 that received an injection of triazolam at CT 24 on days 1 and 9 of DD is shown on the bottom right panel of Figure 3 .
EIGHT-HOUR ADVANCE SHIFT IN THE LD CYCLE
Following the 8-hr advance in the LD cycle, all the animals injected with vehicle began their activity earlier each day until eventually the onset of activity once again occurred near the time of lights-off, with the mean transient period of the group lasting 23 ± 2 days. The activity rhythms in five of eight animals injected with triazolam were resynchronized to the new LD cycle within 2-4 days after the shift in the LD cycle. In one hamster treated with triazolam, no phase shift in the activity rhythm was observed the day after the 8-hr advance in the LD cycle, whereas in the two remaining triazolam-treated animals the activity rhythms were phase-delayed by 60-70 min the day after the change in the LD cycle. The activity rhythms of these three animals only re-entrained after about 20 days of exposure to the new FIGURE 3. Left: Mean ( ± SEM) phase shifts m the activity rhythm of hamsters that were injected with 2.5 mg of triazolam at CT 24 after various time intervals following the transfer from either LD 14:10 (top panel) or LD 12:12 (bottom panel) to DD. A value above the straight line at 0 indicates a mean advance in the onset of locomotor activity; a value below indicates a mean delay. Numbers at the bottom of each bar indicate the day after transfer to DD at which triazolam treatment was administered to the animals. The values within parentheses indicate the numbers of trials performed on each day tested. The groups designated by a star refer to animals that were subjected to only one injection of triazolam on day 24 or 39 of DD, after transfer from LD 14:10 or LD 12:12, respectively. Right: Representative sections from the activity records of hamsters injected with 2.5 mg of triazolam at CT 24, on days 1 and 8 after transfer from LD 14:10 to DD (top panel) or on days 1 and 9 after transfer from LD 12:12 to DD (bottom panel). In both experimental conditions, treatment with triazolam at CT 24 induced phase advances in the activity rhythm on day 1 and phase delays on days 8-9 of DD. LD cycle. The mean number of days necessary for the activity rhythms of all eight triazolamtreated animals to be resynchronized to the new LD cycle was 9 ± 4 days, a value significantly lower (p < 0.005, unpaired Student's t test) than the transient period of the vehicle-treated animals. Representative activity records for a control animal and for one of the five animals showing rapid re-entrainment to the new light cycle in response to triazolam treatment are shown in Figure 4 . Representative sections of the activity records from two hamsters subjected to an 8-hr advance in LD 14:10 on day 7. The LD cycle before and after the shift is shown above each record. On the day of the shift, the animals received a single injection of either vehicle (V, top panel) or 2.5 mg of triazolam (T, bottom panel) 12 hr after the onset of activity on that day (i.e., CT 24). The activity rhythm of the hamster injected with vehicle was re-entrained to the new LD cycle after about 25 days, whereas that of the triazolam-treated animal was resynchronized within 3 days after the shift in the LD cycle. See Figure 2 for further details.
DISCUSSION
Results of the first experiment indicate that the PRC generated in hamsters in response to triazolam during the first day after transfer from LD 14:10 to DD (PRCLD) is very different from the PRC to triazolam generated in hamsters free-running in DD for many cycles before treatment (PRCDD) (Fig. 1) (Turek and Losee -Olson, 1986 ). The duration of the phase advance region of PRCLD is much larger, with the onset of the advance region occurring about 6 hr earlier but ending at about the same CT. The maximum phase advances for PRCLD occur from about CT 24 to CT 3, while the maximum phase advances for PRCDD occur at about CT 6 and CT 9. In addition, the amplitude of maximal phase advances is also much larger in PRCLD, and the transition from phase delays to phase advances appears to be much more abrupt in PRCLD, Although the injection volume was 0.1 ml in the present experiments and 0.5 ml in our previously published PRC for triazolam, we have never noted any effect of volume on the response to triazolam. A second difference between the two studies was that we calculated phase shifts in the present study using activity onsets 5-10 days after treatment, whereas in the previous study days 2-7 were used. However, phase shifts in response to triazolam are complete within 1-2 days, and in both studies phase shifts were determined by using activity onsets after a steady state in the phase of activity onset had been achieved. Thus, the differences in the two PRCs to injections of triazolam appear to be attributable to the time in DD before treatment.
Additional support for the hypothesis that the shape of the PRC to triazolam changes as a function of time spent in DD is provided by the findings that in animals transferred from LD 14: 10 to DD, treatment with triazolam at CT 24 results in large phase advances when the drug is given during the first day after transfer to DD, but in phase delays when it is given after many cycles in DD (Fig. 3 ). In addition, the phase-shifting effects of triazolam on the activity rhythms of hamsters transferred from LD 12:12 to DD are also modified as a function of time spent in DD: Triazolam given at CT 24 results in larger phase advances on the first day after transfer to DD, but in phase delays when it is given after many cycles in DD (Fig. 3 ).
The differences between the phase-shifting effects of triazolam on the activity rhythm after 1 day in DD and the effects after many days in DD may be attributable to an altered phase relationship between the activity rhythm and the circadian clock under these two environmental conditions. That is, an injection of triazolam administered at the same phase of the activity rhythm (e.g., 12 hr after the onset of locomotor activity) may not be coincident with the same phase of the circadian clock after I day in DD as after many days in DD. This explanation appears unlikely, however, since both the larger magnitude of phase advances in PRCLD and the finding that the end of the phase advance region occurs at the same CT in the two PRCs indicates that PRCLD is not just a shift of PCRDD relative to activity onset; rather, the two PRCs are different from each other.
It is interesting to note that whereas changes in the period of the activity rhythm have been observed to occur over many weeks under constant lighting conditions, the change in the shape of the PRC may be complete within just a few days. Although we did not examine the time course for changes in the shape of the complete PRC to triazolam, the response to phase shifts induced by injections of triazolam at CT 24 suggests that the response at this CT remains the same after 8-9 days in DD.
Acute changes in locomotor activity in response to a variety of pharmacological and nonpharmacological stimuli are thought to underlie the phase-shifting effects of these stimuli on the circadian system (Mrosovsky, 1988; Turek, 1989) . There is now convincing evidence that the phase-shifting effects of triazolam on the circadian clock of hamsters are mediated by the stimulation of physical activity associated with triazolam treatment in this species (Van Reeth and Turek, 1989) . Indeed, both phase advances and phase delays in the circadian rhythm of activity, which are normally induced by a single injection of triazolam in freerunning animals, can be totally blocked simply by immobilizing the animal or restricting its movements during the 6 hr after treatment (Van Reeth and Turek, 1989) . These observations, coupled with the present results, suggest that the changes in the PRC to triazolam actually reflect changes in the PRC to activity-inducing stimuli. It remains to be determined whether the response of the circadian clock to other activity-inducing stimuli (e.g., pulses of darkness on a background of constant light, exposure to a novel running wheel) (Reebs and Mrosovsky, 1989; Van Reeth and Turek, 1989 ) also varies as a function of the time spent in constant lighting conditions.
We have previously demonstrated that a single injection of triazolam given 6 hr before the onset of activity reduces the time necessary for the activity rhythm of hamsters to be resynchronized after an 8-hr shift in the LD cycle (Van Reeth and Turek, 1987) . The time selected for triazolam administration was based on the results of experiments indicating that triazolam given at CT 6 in animals free-running for many cycles in DD induces maximal phase advances in the activity rhythm (Turek and Losee-Olson, 1986 ). Although triazolam reduced the transient period by ==50% in this experiment, none of the triazolam-treated animals were resynchronized to the new LD cycle in fewer than 3 days (Van Reeth and Turek, 1987) . In the present study-which employed a similar protocol except for the time of triazolam administration (i.e., 12 hr after the onset of activity instead of 6 hr before the onset of activity), which was selected on the basis of the characteristics of PRCLD-five of eight animals appeared to resynchronize to the new LD cycle within a few days after the shift. Whether or not the rapid re-entrainment of activity onset in triazolam-treated animals following an 8-hr advance in the LD cycle reflects a rapid phase shift in the underlying circadian pacemaker, or an uncoupling of activity onset and the pacemaker, was not determined in the present study because the animals were not allowed to free-run in DD after the apparent re-entrainment to the new LD cycle. However, Mrosovsky (1989) has demonstrated that the pacemaker underlying the rhythm of activity does shift to about the same degree as activity onset in hamsters that show accelerated re-entrainment to a phase-shifted light cycle after treatment with an activity-inducing stimulus. It is noteworthy that two of eight animals injected with triazolam at CT 24 were phase-delayed instead of being phase-advanced. Considering the sharpness of the transition between the phase delay and the phase advance regions of PRCLD, a small interindividual variation in the PRC to triazolam may explain the findings for these two animals.
The results of the present experiments suggest that PRCs generated in response to phaseshifting stimuli during the first day in DD may provide more useful information in attempting to manipulate the circadian clock under entrained conditions than may PRCs generated after many cycles in constant environmental conditions. If this is also the case for the response of the human circadian clock to phase-shifting stimuli, then any attempt to define the optimal time for shifting human circadian rhythms by pharmacological or nonpharmacological means should be based on the response of the clock to a particular stimulus under entrained conditions, or during the transition from entrained to free-running conditions. REEBS, S., and N. MROSOVSKY (1989) 
